Phase 1 (based on three levels of Peg/Ruxo dosage) concluded, now starting Phase 2 Blind Trial to optimise dosage levels.
Early results appear encouraging
Phase 1 (based on three levels of Peg/Ruxo dosage) concluded, now starting Phase 2 Blind Trial to optimise dosage levels.
Early results appear encouraging
Thank you Paul, very encouraging and provides hope.
Hi Paul. Thanks so much for this. I’m seeing the Oxford MPN specialist at the. Churchill Hospital ( which I’d recommend) in a couple of weeks, and I’d like to know from him if, on the light of this research, peg might be a possible addition for me if things get bad. Who am I kidding. When things get bad. I have PMF.
I’ve been getting printouts of my results from the excellent Australian CNS there without it feeling like a big ask. Which it has at the other hospitals I’ve been to.
All the best, and do keep the research updates flowing.
All,the best
Rachel
Hey Paul...
Yes, it is always encouraging but the sample sizes thus far are very small indeed...
Hopefully, more conclusive results will be forthcoming in the not-to-distant future...
Best wishes to all...
Steve
(Sydney)
Fab news